BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5755197)

  • 21. [Activity of enzymes catalyzing degradation of biologically active substances in drug allergy in children with tuberculosis].
    Kazakov KS; Piataeva EV; Sidorova LL
    Probl Tuberk; 1983 Jun; (6):34-7. PubMed ID: 6410374
    [No Abstract]   [Full Text] [Related]  

  • 22. [A paranoid syndrome after discontinuing tuberculostatics].
    Müller N; Günther W; Müller-Felber W
    Dtsch Med Wochenschr; 1991 Dec; 116(50):1934. PubMed ID: 1748074
    [No Abstract]   [Full Text] [Related]  

  • 23. [2 cases of acute side effects in the use of antitubercular preparations].
    Tsereteli AN; Shcherbakov AI
    Probl Tuberk; 1968; 46(9):85-6. PubMed ID: 5718441
    [No Abstract]   [Full Text] [Related]  

  • 24. [Side effects in pulmonary tuberculosis patients in different chemotherapy methods].
    Gol'dshteĭn VD; Prokhorov EP
    Probl Tuberk; 1981 Oct; (10):37-40. PubMed ID: 7312849
    [No Abstract]   [Full Text] [Related]  

  • 25. [Side effects of antibacterial drugs in the clinical course of pulmonary tuberculosis].
    Czkwianianc M; Markiewicz I
    Przegl Lek; 1969 Jun; 25(6):479-81. PubMed ID: 5805095
    [No Abstract]   [Full Text] [Related]  

  • 26. [The influence of therapeutical and biological parameters on the appearance of side effects and complaints during intermittent chemotherapy of pulmonary tuberculosis (author's transl)].
    Eule H; Iwainsky H
    Prax Klin Pneumol; 1981 Aug; 35(8):347-53. PubMed ID: 7345430
    [No Abstract]   [Full Text] [Related]  

  • 27. A resected case of Mycobacterium szulgai pulmonary disease.
    Tsuyuguchi K; Amitani R; Matsumoto H; Tanaka E; Suzuki K; Yanagihara K; Mizuno H; Hitomi S; Kuze F
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):258-60. PubMed ID: 9526201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Side effects in therapy of patients with pulmonary tuberculosis].
    Gromilina GP; Lobkovskaia GI
    Med Sestra; 1973 Mar; 32(3):12-4. PubMed ID: 4490299
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

  • 30. [The experimental study of the effect of an association of reserpine and tolbutamide on gastric activity].
    Mihăilescu M
    Fiziol Norm Patol; 1966; 12(5):443-8. PubMed ID: 5975704
    [No Abstract]   [Full Text] [Related]  

  • 31. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ethionamide in the treatment of patients infected with drug resistant bacilli].
    Pregowski W; Zagórecka A
    Pol Tyg Lek; 1966 May; 21(22):833-7. PubMed ID: 5962181
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lactate dehydrogenase isoenzymes in pulmonary tuberculosis patients with manifestations of the adverse effects of antitubercular preparations].
    Kotenko AP
    Probl Tuberk; 1983 Jul; (7):27-30. PubMed ID: 6634674
    [No Abstract]   [Full Text] [Related]  

  • 34. [Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].
    Ubaĭdullaev AM; Tashpulatova FK; Kazakov KS
    Probl Tuberk; 1998; (4):23-4. PubMed ID: 9771032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of ethionamide in the clincal treatment of pulmonary tuberculosis].
    Mamolat AS; Bialik IB
    Vrach Delo; 1965 Jun; 6():35-9. PubMed ID: 5856046
    [No Abstract]   [Full Text] [Related]  

  • 36. Gynecomastia in multi-drug resistant tuberculosis - ethionamide the villain.
    Deokar K; Shaikh AL; Chawla G
    Adv Respir Med; 2020; 88(2):162-163. PubMed ID: 32383471
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the "cholinergic" mechanism of the action of morphine].
    Chodera A; Konys J; Stasińska M; Szpunar K
    Acta Physiol Pol; 1969; 20(2):345-52. PubMed ID: 5788454
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of tetraalkylammonium ions on the thermal inactivation of cholinesterases].
    Grigor'eva GM
    Biokhimiia; 1966; 31(4):736-9. PubMed ID: 5999961
    [No Abstract]   [Full Text] [Related]  

  • 40. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.